Susquehanna International Group, LLP Unity Biotechnology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $4.27 $139,400 - $1.49 Million	348,500 Added 823.88%	390,800 $156,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $21,240 - $54,870	29,500 Added 230.47%	42,300 $47,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $6,402 - $9,900	2,200 Added 20.75%	12,800 $38,000
Q2 2021 Aug 11, 2021	SELL	$4.15 - $6.3 $323,285 - $490,770	-77,900 Reduced 88.02%	10,600 $49,000
Q1 2021 May 17, 2021	BUY	$5.51 - $9.42 $409,944 - $700,848	74,400 Added 527.66%	88,500 $531,000
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $146,034 - $271,572	-42,700 Reduced 75.18%	14,100 $74,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $82,320 - $348,040	28,000 Added 97.22%	56,800 $197,000
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $94,512 - $173,093	17,900 Added 164.22%	28,800 $250,000
Q1 2020 May 15, 2020	BUY	$5.0 - $7.6 $54,500 - $82,840	10,900 New	10,900 $63,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.